Foundation Medicine Revenue, Profits - FMI Annual Income Statement

Add to My Stocks
$137 $0 (0%) FMI stock closing price Jul 31, 2018 (Closing)

Stock analysis based on fundamentals means looking at financial statements in addition to the Foundation Medicine stock price. In the income statement, an investor can look at important parameters like revenue or sales, gross profits, net profits, and EPS basic to gain deeper insights. The income statement is always for an accounting period, typically for a year or quarter, and affects the stock. In this case, the FMI stock is bound to reflect the impact of the YOY growth of 30.84%. Along with Foundation Medicine assets and Foundation Medicine free cash flow, Foundation Medicine profits as shown in profit and loss statement give key insights about the business. The net profit for 2017 is $-161.46M and the 2017 revenue is $152.9M.

View revenue and profit details for latest and last 10 financial years.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Foundation Medicine Revenues or Net Sales
152.9M116.86M93.2M61.07M28.99M10.64M2.05M
Cost Of Goods Sold (COGS)85.27M56.74M39.43M27.43M11.65M5.68M-
Foundation Medicine Gross Profit
67.63M60.11M53.77M33.64M17.33M4.96M1.79M
Research & Development Expense91.5M67.37M43.88M30.62M24.9M14.77M9.02M
Selling General & Admin Expense137.06M106.56M99.64M56.29M34.19M12.09M8.54M
Income Before Depreciation Depletion Amortization-160.94M-113.81M-89.75M-53.28M-41.76M-21.91M-15.77M
Depreciation Depletion Amortization-------
Non Operating Income-0.52M--1.1M-0.94M-0.06M-0.84M
Interest Expense---0.12M----
Foundation Medicine Pretax Income
-161.46M-113.19M-89.63M-52.22M-42.94M-22.39M-17.03M
Provision for Income Taxes-------
MinorityInterest-------
Investment Gains Losses-------
Other Income-------
Income Before Extraordinaries & Disc Operations-161.46M-113.19M-89.63M-52.22M-42.94M-22.39M-17.03M
Extraordinary Items & Discontinued Operations-------
Foundation Medicine Profit/ Loss (Net Income)
-161.46M-113.19M-89.63M-52.22M---17.03M
Average Shares used to compute Diluted EPS35.88M34.79M32.84M27.95M9.3M13.91M-
Average Shares used to compute Basic EPS35.88M34.79M32.84M27.95M9.3M13.91M-
Income Before Nonrecurring Items-161.47M-113.19M-75.28M-52.22M-39.6M22.39M-
Income from Nonrecurring Items---14.35M--3.35M--
Foundation Medicine Earnings Per Share Basic Net
-4.50-3.25-2.73-1.87-4.641.63-
Foundation Medicine Earnings Per Share Diluted Net
-4.50-3.25-2.73-1.87-4.641.63-
EPS Diluted Before Nonrecurring Items-4.50-3.25-2.31-1.87-4.281.63-
Preferred Dividends Acc Pd-------
Dividends Common-------
Dividend Per Share Common0.000.000.000.000.000.000.00
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

The key things to look for in an income statement while doing Foundation Medicine stock analysis are:

  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that FMI stock has a topline or revenue of $152.9M for 2017 as per this Foundation Medicine revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. FMI stock had a poor bottom line growth.

The income statement is also called statement of revenue and expense. The FMI financials along with Foundation Medicine historical stock prices provide a lot of details about the firm.

Foundation Medicine Income Statement - Key Financial Ratios

PS Ratio (price sales ratio)
28.05
Dividend Yield
0%